Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
In recent years, deaths from non-small cell lung cancer (NSCLC) have decreased even faster than the decrease in NSCLC incidence.
Screening would be especially cost effective in high-income nations.
Building transvisibility in cancer genetic counseling
A vote of confidence for a new, high-tech frontier in oncology
To take advantage of these new therapies, people must first learn whether their cancer harbors targetable mutations.
Task force recommends BRCA screening for women at increased cancer risk
New site-agnostic therapies highlight the importance of genetic testing.
The bottom line is that people risk not having their genetic alterations identified if they do not have genetic consultations.
Quincy’s treatment would take him and his family to the frontier of using precision medicine to find a drug to save the infant’s life.
Experts advise screening for those with a personal or family history of breast or ovarian cancer, but not for all women.
Capitalizing on the growing popularity of genetic testing, scammers are persuading seniors to take two types of genetic screenings.
About a year after Aunt Pat’s death, I started the process of collecting my family’s health history, and shared it with my doctor.
New prognostic tests may help thousands of women safely forgo expensive chemotherapy.
Tests for inherited genetic mutations can provide women diagnosed with ovarian or breast cancer with important information.
New genetic testing from Invitae shows how genetic abnormalities in prostate cancer patients can affect both future and family cancer risks.
New database provides information on gene variants to clinicians, researchers and patient advocates around the world.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.